TAK-875
Jump to navigation
Jump to search
Indications
Mechanism of action
- agonist of free fatty acid receptor 1 (FFAR1)
- stimulates insulin secretion with rising plasma glucose
More general terms
References
- ↑ Burant CF et al TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo- controlled trial The Lancet, Early Online Publication, 27 February 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22374408 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61879-5/fulltext
Bailey CJ Could FFAR1 assist insulin secretion in type 2 diabetes? The Lancet, Early Online Publication, 27 February 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22374407 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60165-2/fulltext